Prof. Dr. Bernhard Scheuble, chief executive of Merck KGaA p

GERMANY - FEBRUARY 16: Prof. Dr. Bernhard Scheuble, chief executive of Merck KGaA pauses during a press conference in Darmstadt, Germany, Monday, February 16, 2004. Germany's fourth-biggest drugmaker, will sell its VWR International laboratory products business for $1.68 billion to U.S. buyout firm Clayton, Dubilier & Rice Inc., leaving Merck almost free of debt. (Photo by Wolfgang Von Brauchitsch/Bloomberg via Getty Images)
GERMANY - FEBRUARY 16: Prof. Dr. Bernhard Scheuble, chief executive of Merck KGaA pauses during a press conference in Darmstadt, Germany, Monday, February 16, 2004. Germany's fourth-biggest drugmaker, will sell its VWR International laboratory products business for $1.68 billion to U.S. buyout firm Clayton, Dubilier & Rice Inc., leaving Merck almost free of debt. (Photo by Wolfgang Von Brauchitsch/Bloomberg via Getty Images)
Prof. Dr. Bernhard Scheuble, chief executive of Merck KGaA p
PURCHASE A LICENSE
How can I use this image?
kr 2,500.00
NOK
Getty ImagesProf. Dr. Bernhard Scheuble, chief executive of Merck KGaA p, News PhotoProf. Dr. Bernhard Scheuble, chief executive of Merck KGaA p, News PhotoProf. Dr. Bernhard Scheuble, chief executive of Merck KGaA p Get premium, high resolution news photos at Getty ImagesProduct #:94887598
kr4,000kr950
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg’s prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
94887598
Collection:
Bloomberg
Date created:
February 16, 2004
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
pdir0276\Hi_j0242.JPG